15.3 Healthcare Infection Prevention and Environmental Transmission

Healthcare Infection Prevention and Environmental Transmission

Hospital-acquired infections (HAIs)—including central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), surgical site infections (SSIs), and facility-acquired Clostridioides difficile—cause substantial morbidity, excess mortality, and significant financial penalties under national quality reporting programs. Preventing healthcare-associated transmission demands a rigorous understanding of microbial transmission dynamics, strict enforcement of Standard and Transmission-Based Precautions, implementation of evidence-based clinical care bundles, and systematic environmental decontamination.

---

Dynamics of Microbial Transmission in Healthcare Environments

Microorganisms transmit through acute care and ambulatory settings via well-defined physical mechanisms:

                     MODES OF HEALTHCARE TRANSMISSION

   CONTACT TRANSMISSION                DROPLET TRANSMISSION
  ┌───────────────────────────┐       ┌───────────────────────────┐
  │ Direct (body surface) or  │       │ Large particles (> 5–10 μm)│
  │ Indirect (fomite/equipment)│      │ Ballistic flight ≤ 3–6 ft │
  │ MRSA, VRE, CRE, C. diff   │       │ Influenza, N. meningitidis│
  └───────────────────────────┘       └───────────────────────────┘
                AIRBORNE TRANSMISSION          ENVIRONMENTAL / WATERBORNE
  ┌───────────────────────────┐       ┌───────────────────────────┐
  │ Droplet nuclei (≤ 5 μm)   │       │ Biofilms in plumbing, sink│
  │ Suspended in air currents │       │ traps, cooling towers     │
  │ TB, Measles, Varicella    │       │ Legionella, Pseudomonas   │
  └───────────────────────────┘       └───────────────────────────┘

1. Contact Transmission:
   • Direct Contact: Physical transfer of microorganisms between an infected or colonized patient and a susceptible host (e.g., healthcare personnel hands during physical examination or patient repositioning).
   • Indirect Contact: Involves personal contact of a susceptible host with a contaminated inanimate intermediate object (fomite), such as shared stethoscopes, blood pressure cuffs, glucometers, bed rails, or unwashed computer keyboards.
2. Droplet Transmission:
   • Microorganisms propelled through the air in large respiratory droplets (> 5 to 10 μm) generated during coughing, sneezing, talking, or airway suctioning.
   • Droplets follow ballistic trajectories and travel only short distances through the air (typically ≤ 3 to 6 feet) before depositing onto the conjunctiva, nasal mucosa, or oral membranes of a susceptible host.
   • Does not remain suspended in the air; does not require specialized negative-pressure ventilation.
3. Airborne Transmission:
   • Microorganisms dispersed in microscopic droplet nuclei (≤ 5 μm) or evaporated respiratory residues that remain suspended in ambient air currents indefinitely.
   • Infectious particles travel long distances throughout rooms and ventilation ducts and are inhaled deeply into the terminal bronchioles and pulmonary alveoli.
   • Requires specialized environmental negative-pressure ventilation to prevent transmission.
4. Environmental and Waterborne Reservoirs:
   • Hospital water distribution systems and premise plumbing harbor complex biofilms supporting Legionella pneumophila, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and non-tuberculous mycobacteria (NTM).
   • Sink drain traps represent high-risk colonization reservoirs for carbapenemase-producing Enterobacterales; aerators and turbulent water impact create infectious splashback aerosols contaminating nearby sterile supplies and patient care items.

---

Standard and Transmission-Based Precautions

Healthcare isolation practices are organized into two tiers: universal Standard Precautions applied to all patient encounters, and Transmission-Based Precautions applied based on documented or suspected pathogen transmission modes.

1. Standard Precautions: The Universal Baseline

Standard Precautions apply to all patients in all healthcare settings, regardless of suspected infection status:

• Hand Hygiene: The cornerstone of infection control.
  • Alcohol-Based Hand Rub (ABHR): Solutions containing 60% to 95% ethanol or isopropanol represent the gold standard for routine hand decontamination before and after direct patient contact, after touching medical equipment, and before aseptic procedures. Alcohols rapidly denature microbial proteins and dissolve lipid bilayer membranes, achieving superior bactericidal efficacy in 15 to 20 seconds compared to soap and water.
  • The Sporicidal Exception (Soap and Water Mandate): Alcohols possess zero sporicidal activity. The complex, multilayered protein spore coat of bacterial endospores (Clostridioides difficile) and the rigid, non-enveloped protein capsid of enteric viruses (Norovirus) resist alcohol denaturation. When caring for patients with confirmed or suspected C. difficile or norovirus, when hands are visibly soiled with blood or proteinaceous material, or after using the restroom, personnel must perform mechanical hand washing with soap and water for at least 20 seconds. Soap and running water physically detach and flush spores off the skin surface.
• Personal Protective Equipment (PPE): Donned based on anticipated exposure to blood, body fluids, secretions, excretions, non-intact skin, or mucous membranes (gloves, fluid-resistant gowns, surgical masks, eye protection).
• Respiratory Hygiene / Cough Etiquette: Source control (masking symptomatic individuals), spatial separation (≥ 3 feet), and disposal of tissues.
• Safe Injection Practices: "One needle, one syringe, only one time." Single-dose medication vials must never be accessed with a used syringe or needle, and multi-dose vials must be dedicated to a single patient whenever feasible.

2. Transmission-Based Precautions

                  AIRBORNE INFECTION ISOLATION ROOM (AIIR)

 ┌────────────────────────────────────────────────────────────────────────┐
 │ Air Inflow from Corridor ──► Door Remains CLOSED AT ALL TIMES          │
 │                                                                        │
 │        Negative Pressure Differential: ≥ 2.5 Pascals (0.01 in H2O)    │
 │                                                                        │
 │        Continuous Airflow Velocity: ≥ 12 Air Changes Per Hour (ACH)    │
 │                                                                        │
 │ Exhaust Air ──► 100% Directly Exhausted Outdoors (Away from Inlets)    │
 │                 OR Filtered Through Certified HEPA Filter              │
 └────────────────────────────────────────────────────────────────────────┘

---

Device-Associated and Surgical Infection Prevention Bundles

Clinical care bundles are structured groupings of evidence-based interventions that, when executed collectively and reliably, dramatically reduce device-associated HAIs.

1. Central Line-Associated Bloodstream Infection (CLABSI) Bundle

• Insertion Bundle (Mandatory Sterile Practices):
  • Optimal Site Selection: Subclavian vein is preferred for non-tunneled central venous catheters (CVCs) in adults. The internal jugular vein is acceptable but carries higher oropharyngeal microbial colonization. The femoral vein is strictly avoided in adults due to heavy perineal bacterial contamination, high CLABSI rates, and deep vein thrombosis risk.
  • Skin Antisepsis: > 0.5% chlorhexidine gluconate (CHG) with 70% isopropyl alcohol applied with a vigorous back-and-forth friction scrub for ≥ 30 seconds and allowed to air dry completely (minimum 2 minutes). Do not wipe or blot dry.
  • Maximal Sterile Barrier (MSB) Precautions: The inserter must wear a sterile gown, sterile gloves, cap, and surgical mask with eye protection; the patient is covered head-to-toe with a large sterile full-body drape.
  • Ultrasound Guidance: Mandatory for internal jugular placement to minimize mechanical complications.
• Maintenance Bundle:
  • Daily Necessity Review: Daily evaluation of line necessity with immediate removal of unneeded catheters.
  • Disinfection of Access Hubs: "Scrub the hub" for 10 to 15 seconds with chlorhexidine-alcohol or 70% alcohol pads prior to every line entry, allowing to air dry.
  • Dressing Integrity: Transparent semipermeable membrane dressings changed every 7 days (or every 48 hours for gauze dressings), or immediately if loose, soiled, or damp.
  • Daily CHG Bathing: Daily chlorhexidine skin cleansing in ICU patients aged ≥ 2 months reduces bloodstream seeding from skin flora.

2. Catheter-Associated Urinary Tract Infection (CAUTI) Bundle

• Appropriate Clinical Indications for Indwelling Catheterization:
  • Acute urinary retention or bladder outlet obstruction.
  • Precise hourly urine volume measurement in critically ill, hemodynamically unstable patients.
  • Perioperative management for selected urologic/gynecologic surgeries or prolonged operative times.
  • Facilitation of healing in open stage III or IV pressure ulcers in the sacral or perineal region in incontinent patients.
  • Palliative end-of-life care.
  • Inappropriate Indications: Convenience of staff, routine urine output measurement in non-critical patients, or incontinence management without open sacral wounds.
• Maintenance Essentials:
  • Maintain an uninterrupted closed drainage system.
  • Maintain downward gravity flow: Keep catheter tubing free of kinks and dependent loops; keep the collection bag below the level of the bladder at all times to prevent retrograde reflux of colonized urine into the bladder.
  • Secure the catheter to the patient's thigh to prevent urethral traction and trauma.
  • Routine catheter irrigation or routine surveillance urine cultures are contraindicated.

3. Ventilator-Associated Event (VAE / VAP) Bundle

• Head-of-Bed Elevation: Maintain bed elevation at 30° to 45° continuously (unless medically contraindicated) to prevent passive gastroesophageal reflux and aspiration of gastric secretions.
• Daily Sedation Interruption and Spontaneous Breathing Trials (SBT): Daily coordinated "sedation vacation" to assess readiness for extubation, shortening total ventilator days.
• Subglottic Secretion Drainage (SSD): Use specialized endotracheal tubes equipped with a continuous or intermittent subglottic suction port to remove pooled oropharyngeal secretions above the cuff in patients expected to be intubated for > 48 to 72 hours.
• Oral Care: Comprehensive oral hygiene, including mechanical toothbrushing and antiseptics.
• Peptic Ulcer Disease (PUD) Prophylaxis and Deep Vein Thrombosis (DVT) Prophylaxis.

4. Surgical Site Infection (SSI) Prevention Bundle

                    PERIOPERATIVE SSI PREVENTION TIMELINE

  Pre-Op (60 min pre-incision)   Intra-Operative                  Post-Operative
 ┌────────────────────────────┐ ┌──────────────────────────────┐ ┌───────────────┐
 │ • Cefazolin IV infusion    │ │ • Normothermia (≥ 35.5–36°C) │ │ • D/C Abx     │
 │   (120m for Vanc / FQ)     │ │ • Glycemic Control (< 180)   │ │   strictly    │
 │ • Hair clipping (NO RAZORS)│ │ • Redose Abx every 1–2 t1/2  │ │   ≤ 24 hours  │
 │ • CHG-alcohol skin prep    │ │ • Maintain tissue FiO2       │ │   post-op     │
 └────────────────────────────┘ └──────────────────────────────┘ └───────────────┘

• Perioperative Antimicrobial Prophylaxis Timing and Dosing:
  • Administer IV antibiotic prophylaxis within 60 minutes prior to surgical incision (extended to 120 minutes for vancomycin or fluoroquinolones to avoid infusion-related reactions).
  • Weight-based dosing: Cefazolin 2 g for patients < 120 kg; 3 g for patients ≥ 120 kg.
  • Intraoperative redosing: Redose antimicrobial if surgery exceeds 1 to 2 half-lives of the drug (e.g., redose cefazolin every 4 hours from initial dose), or with massive blood loss (> 1,500 mL).
  • Discontinuation: Stop prophylaxis within 24 hours postoperatively (or at wound closure). Prolonging antibiotics beyond 24 hours does not decrease SSI and induces antimicrobial resistance.
• Hair Removal: If hair removal is necessary, use electric clippers immediately prior to surgery. Razors are strictly prohibited because razor shaving causes microscopic dermal lacerations that become colonized with bacteria, doubling SSI rates.
• Normothermia: Maintain core body temperature ≥ 35.5°C to 36.0°C throughout surgery (hypothermia induces peripheral vasoconstriction, reduces tissue oxygen tension, and impairs neutrophil phagocytic killing).
• Perioperative Glycemic Control: Maintain blood glucose < 180 mg/dL in all patients (diabetic and non-diabetic).

---

Medical Device Reprocessing and Environmental Decontamination

1. The Spaulding Classification System

Formulated by Dr. Earle Spaulding, this framework dictates the necessary level of disinfection or sterilization based on the degree of infection risk associated with the device's clinical use.

                       SPAULDING CLASSIFICATION PYRAMID

                                  ▲
                                 /│\
                                / │ \
                               /  │  \
                              /   │   \
                             / CRITICAL \
                            /  (Sterility)  \
                           /─────────────────\
                          /   SEMI-CRITICAL   \
                         /   (High-Level Dis.) \
                        /───────────────────────\
                       /      NON-CRITICAL       \
                      / (Low/Intermediate Disinf) \
                     /─────────────────────────────\

1. Critical Items:
   • Tissue Contact: Instruments entering sterile body tissues, the vascular system, or sterile body cavities.
   • Examples: Surgical scalpels, forceps, implants, cardiac catheters, arthroscopes, laparoscopes, biopsy forceps passed through endoscopes.
   • Required Reprocessing: Sterilization (complete destruction of all microbial life, including all vegetative bacteria, mycobacteria, bacterial endospores, fungi, and viruses).
   • Methods: High-pressure saturated steam autoclaving (preferred), ethylene oxide (EtO) gas (for heat-sensitive items), vaporized hydrogen peroxide (VHP), peracetic acid immersion.
2. Semi-Critical Items:
   • Tissue Contact: Devices coming into contact with intact mucous membranes or non-intact skin, but not penetrating sterile tissue.
   • Examples: Flexible gastrointestinal endoscopes, bronchoscopes, transesophageal echocardiography (TEE) probes, endotracheal tubes, respiratory therapy equipment, vaginal/rectal ultrasound probes.
   • Required Reprocessing: High-Level Disinfection (HLD) (destroys all vegetative bacteria, mycobacteria, viruses, and fungi; may not kill all bacterial endospores).
   • Chemical Agents: Glutaraldehyde (≥ 2.0%), Ortho-phthalaldehyde (OPA 0.55%), Hydrogen peroxide (7.5%), Peracetic acid (0.2%). Requires strict validation of contact time, temperature, and chemical test strip verification of the Minimum Effective Concentration (MEC) prior to every cycle.
3. Non-Critical Items:
   • Tissue Contact: Items contacting only intact, healthy skin.
   • Examples: Bedpans, blood pressure cuffs, crutches, stethoscopes, bed rails, bedside tables, computer keyboards, IV poles.
   • Required Reprocessing: Low-to-Intermediate Level Disinfection (destroys vegetative bacteria, most fungi, and enveloped viruses; does not reliably kill mycobacteria or bacterial endospores).
   • Chemical Agents: Quaternary ammonium compounds, 70% to 90% isopropyl alcohol, phenolic compounds, accelerated hydrogen peroxide.

2. Sporicidal Environmental Cleaning for Clostridioides difficile

Clostridioides difficile endospores persist on dry hospital surfaces for months, resisting desiccation and common quaternary ammonium hospital disinfectants.

• Sporicidal Disinfectant Standard: Terminal cleaning of rooms vacated by patients with C. difficile mandates an EPA-registered sporicidal disinfectant, most commonly sodium hypochlorite (dilute household bleach at a 1:10 dilution, yielding approximately 5,000 ppm available chlorine).
• Adjunctive No-Touch Technologies: Following manual physical cleaning, automated Ultraviolet-C (UV-C) light towers (emitting radiation at 254 nm to disrupt microbial DNA) or Vaporized Hydrogen Peroxide (VHP) systems can be deployed as secondary adjuncts to decontaminate shadowed surfaces and reduce residual spore loads.